Down to ₹53 crore in Q4, Natco Pharma net dips 43%
Declined by 43 per cent to ₹53 crores for the fourth quarter that ended March 31st 2021, the drug firm…
Declined by 43 per cent to ₹53 crores for the fourth quarter that ended March 31st 2021, the drug firm…